Shanghai Pharmaceuticals industry park design (Shanghai Pharma)
Fast-expanding Shanghai Pharma breaks ground on $1.8B biotech park focused on next-gen R&D, antibody production
One of China’s biggest biopharma companies is hitting the ground running in 2021.
Shanghai Pharmaceuticals broke ground Monday on a $1.8 billion, 3.2 million-square-foot industrial …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
